Aldesleukin trials for Lung cancer

6 recruiting trials study Aldesleukin in trials listing Lung cancer in our tracked data. This is not a statement that it treats the condition.

Recruiting trials

Phase breakdown

Early Phase 1 1Phase 1 3Phase 2 4

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
NCT03412877 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 2 locations
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
NCT05296564 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
NCT05483491 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
NCT05493566 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
NCT05267626 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
NCT02133196 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 1 location